Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ballentine Partners LLC boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 26.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,216 shares of the biopharmaceutical company’s stock after buying an additional 8,344 shares during the quarter. […]
McGlone Suttner Wealth Management Inc. lowered its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 35.2% in the 2nd quarter, Holdings Channel reports. The firm owned 5,338 shares of the biopharmaceutical company’s stock after selling 2,895 shares during the period. McGlone Suttner Wealth Management Inc.’s holdings in Bristol-Myers Squibb were worth $341,000 as of […]
WealthPlan Investment Management LLC decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 62.4% in the second quarter, HoldingsChannel reports. The firm owned 2,571 shares of the biopharmaceutical company’s stock after selling 4,267 shares during the quarter. WealthPlan Investment Management LLC’s holdings in Bristol-Myers Squibb were worth $392,000 at the end […]
Albert D Mason Inc. cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,790 shares of the biopharmaceutical company’s stock after selling 985 shares during the period. Albert […]
Eastover Investment Advisors LLC grew its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 71,052 shares of the biopharmaceutical company’s stock after buying an additional 311 shares during the quarter. Bristol-Myers Squibb […]